New York State Common Retirement Fund’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12
| Closed | – | – | 3409 |
|
|
2023
Q2 | $0 | Sell |
12
-957
| -99% | – | ﹤0.01% | 3441 |
|
|
2023
Q1 | $26K | Hold |
969
| – | – | ﹤0.01% | 3096 |
|
|
2022
Q4 | $34K | Hold |
969
| – | – | ﹤0.01% | 3132 |
|
|
2022
Q3 | $219K | Buy |
969
+464
| +92% | +$105K | ﹤0.01% | 2741 |
|
|
2022
Q2 | $95K | Sell |
505
-2
| -0.4% | -$376 | ﹤0.01% | 3088 |
|
|
2022
Q1 | $126K | Buy |
507
+1
| +0.2% | +$249 | ﹤0.01% | 2971 |
|
|
2021
Q4 | $79K | Sell |
506
-3
| -0.6% | -$468 | ﹤0.01% | 3141 |
|
|
2021
Q3 | $102K | Sell |
509
-386
| -43% | -$77.4K | ﹤0.01% | 3135 |
|
|
2021
Q2 | $229K | Buy |
895
+8
| +0.9% | +$2.05K | ﹤0.01% | 2993 |
|
|
2021
Q1 | $236K | Buy |
887
+164
| +23% | +$43.6K | ﹤0.01% | 2775 |
|
|
2020
Q4 | $267K | Buy |
723
+193
| +36% | +$71.3K | ﹤0.01% | 2632 |
|
|
2020
Q3 | $129K | Hold |
530
| – | – | ﹤0.01% | 2826 |
|
|
2020
Q2 | $153K | Hold |
530
| – | – | ﹤0.01% | 2769 |
|
|
2020
Q1 | $108K | Sell |
530
-270
| -34% | -$55K | ﹤0.01% | 2745 |
|
|
2019
Q4 | $358K | Hold |
800
| – | – | ﹤0.01% | 2455 |
|
|
2019
Q3 | $246K | Hold |
800
| – | – | ﹤0.01% | 2667 |
|
|
2019
Q2 | $254K | Buy |
+800
| New | +$254K | ﹤0.01% | 2704 |
|
|
2017
Q2 | – | Sell |
-180
| Closed | -$62K | – | 3253 |
|
|
2017
Q1 | $62K | Hold |
180
| – | – | ﹤0.01% | 3041 |
|
|
2016
Q4 | $63K | Hold |
180
| – | – | ﹤0.01% | 3033 |
|
|
2016
Q3 | $72K | Hold |
180
| – | – | ﹤0.01% | 3042 |
|
|
2016
Q2 | $107K | Buy |
+180
| New | +$107K | ﹤0.01% | 2967 |
|